Left ventricular function and visual phase analysis with equilibrium radionuclide angiography in patients with biventricular device

  • Africa MuxíEmail author
  • Pilar Paredes
  • Lluis Mont
  • Francisco J. Setoain
  • Joan Duch
  • Silvia Fuertes
  • Jaime Ortín
  • Ernesto Diaz-Infante
  • Francisca Pons
Original Article



Cardiac resynchronisation therapy (CRT) is a technique indicated in patients with moderate to severe heart failure and ventricular dyssynchrony. To evaluate left ventricular ejection fraction (LVEF) and synchronisation changes after CRT with a biventricular pacing implant, we used an equilibrium radionuclide angiography (ERNA).


Fifty patients were studied. An ERNA was made 72 h and 6 months after the implant. Two acquisitions were performed: with the CRT device connected and after disconnecting it. In the follow-up, responders were defined as those who had improved in accordance with various clinical variables. Quantitative changes in LVEF and visual changes in synchronisation (phase analysis) were studied comparing the two studies and also comparing the connected and disconnected modes.


At 6 months, 30 patients were defined as responders. LVEF increased significantly at 6 months compared with the 72-h study only in responders. At 72 h, the number of patients showing a decrease in LVEF (p < 0.05) or a synchronisation worsening after disconnecting the device was higher in responders than in nonresponders. At 6 months, 57% of responders had no synchronisation changes between the connected and disconnected modes, suggesting a resynchronisation process.


ERNA permits the study of resynchronisation patients, showing a statistical LVEF improvement at 6 months. Moreover, visual phase analysis permits the study of the mechanism involved in the response, with an important number of responders with no changes between the two modes at 6 months. In the 72-h study, after disconnection of the device, LVEF and resynchronisation worsening can predict patient improvement at 6 months.


Cardiac resynchronisation therapy Heart failure Equilibrium radionuclide angiography Left ventricular ejection fraction Pacing 



The authors wish to thank nuclear medicine technicians, electrophysiological doctors and Mrs. Eulalia Ventura for their skillful help in the realisation of these studies.

Dr. Díaz Infante received a grant from the Spanish Society of Cardiology, Madrid, Spain.

This work was supported by ISCIII (RECAVA).

The authors also would like to thank Bill Mullholand for his editorial assistance.


  1. 1.
    Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art. Cost versus benefit. Circulation 2004;109:300-7.CrossRefPubMedGoogle Scholar
  2. 2.
    Pitzalis MV, Iacoviello M, Romito R, Pietro Guida P, De Tommasi E, Luzzi G, et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol. 2005;45:65-9.CrossRefPubMedGoogle Scholar
  3. 3.
    Bax JJ, Schalij Mj. How to predict response to cardiac resynchronization therapy? Eur Heart J 2005;26(26):1054-5.CrossRefPubMedGoogle Scholar
  4. 4.
    Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 2005;26:1115-40.CrossRefPubMedGoogle Scholar
  5. 5.
    Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352(15):1539-49.CrossRefPubMedGoogle Scholar
  6. 6.
    Bradley DJ. Combining resynchronization and defibrillation therapies for heart failure. JAMA 2003;28(289):2719-21.CrossRefGoogle Scholar
  7. 7.
    Funck RC, Koelsch S, Waldhans S, Prinz H, Grimm W, Moosdorf R, Maisch B. Marked improvement in left ventricular function and significant reverse left ventricular remodeling within 3 months of cardiac resynchronization therapy in patients with dilated cardiomyopathy. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S5-7.CrossRefPubMedGoogle Scholar
  8. 8.
    Vidal B, Sitges M, Marigliano A, Diaz-Infante E, Azqueta M, Tamborero D, et al. Relation of response to Cardiac resynchronization therapy to left ventricular reverse remodelling. Am J Cardiol 2006;97:876-81.CrossRefPubMedGoogle Scholar
  9. 9.
    Molhoek SG, Bax JJ, Bleeker GB, Holman ER, Van Erven L, Bootsma M, Boersma E, Steendijk P, Van Der Wall EE, Schalij MJ. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure. J Cardiovasc Electrophysiol. 2005;16:701-7. Jul.CrossRefPubMedGoogle Scholar
  10. 10.
    Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Multicenter in sync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. Jun 13.CrossRefPubMedGoogle Scholar
  11. 11.
    Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schondube F, Wolfhard U, Bocker D, Krahnefeld O, Kirkels H, Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33. Jun 19.CrossRefPubMedGoogle Scholar
  12. 12.
    Diaz-Infante E, Mont L, Leal J, Garcia-Bolao I, Fernandez-Lozano I, Hernandez-Madrid A, Perez-Castellano N, Sitges M, Pavon-Jimenez R, Barba J, Cavero MA, Moya JL, Perez-Isla L, Brugada J, SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-40. Jun 15.CrossRefPubMedGoogle Scholar
  13. 13.
    Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C de Place C, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Eur Heart J. 2005;26:1094-100.CrossRefPubMedGoogle Scholar
  14. 14.
    Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq Ch, Schalij MJ, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for clinical use? J Am Coll Cardiol. 2004;44:1-9.CrossRefPubMedGoogle Scholar
  15. 15.
    Yu CM, Chan YS, Zhang Q, Yip G, Chan CK, Kum LC, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48:2251-57.CrossRefPubMedGoogle Scholar
  16. 16.
    Bleeker GB, Schalij MJ, Boermn E, Holman ER, Steendijk P, van der Wall EE, Bax JJ. Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2007;99:68-74.CrossRefPubMedGoogle Scholar
  17. 17.
    Tsurugaya H, Taa H, Toyama T, Naiti Sh, Adachi H, Seki R, et al. Usefulness of quantitative gated single-photon emission computed tomography to evaluate ventricular synchrony in patients receiving biventricular device. Am J Cardiol. 2004;94:127-30.CrossRefPubMedGoogle Scholar
  18. 18.
    Trimble MA, Borges-Neto S, Smallheiser S, Chen J, Honeycutt E, Shaw LK, et al. Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol. 2007;14:298-307.CrossRefPubMedGoogle Scholar
  19. 19.
    Ohkuso Y, Takahashí N, Ishikawa T, Sumita Sh, Kobayashi T, Matsushita K, et al. Effect of biventricular pacing on myocardial glucose metabolism in patient with heart failure using Fluoro-18 deoxyglucose positron emission tomography. PACE 2003;26:144-7.CrossRefGoogle Scholar
  20. 20.
    van Campen CMA, Visser FC, van der Weerdt AP, Knaapen P, Comans EF, Lammertsma AA, et al. FDG PET as predictor of response to resynchronization therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2007;34:309-15.CrossRefPubMedGoogle Scholar
  21. 21.
    Toussaint JF, Lavergne T, Kerrou K, Froissart M, Ollitrault J, Darondel JM, et al. Basal asynchrony and resynchronization with biventricular pacing predict long-term improvement of LV function in heart failure patients. PACE. 2003;26:1815-23.CrossRefPubMedGoogle Scholar
  22. 22.
    Eder V, Fauchier L, Corutehoux M, Bonnet P, Babuty D. Segmental wall motion abnormality analyzed by equilibrium radionuclide angiography and improvement in ventricular function by cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30:S58-61.CrossRefPubMedGoogle Scholar
  23. 23.
    Boriani G, Valzania C, Fallani F, Biffi M, Martignani C, Saporito D, et al. Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. Pacing Clin Electrophysiol. 2007;30:S43-6.PubMedGoogle Scholar
  24. 24.
    Kerwin WF, Botvinick EH, O’Conell JW, Merriick SH, DeMarco T, Chatterjee K, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol. 2000;35:1221-7.CrossRefPubMedGoogle Scholar
  25. 25.
    Muramatsu T, Matsumoto K, Nishimura S. Efficacy of the phase images in Fourier analysis using gated cardiac POOL-SPECT for determining the indication for cardiac resynchronization. Circ J. 2005;69:1521-6.CrossRefPubMedGoogle Scholar
  26. 26.
    Dinu C, Kelin G, Morestin-Cadet S, Froissart M, Diebold B, LeHeuzey JY, et al. Gated blood pool tomoscintigraphy with 4-dimensional optical flow motion analysis quantifies left ventricular mechanical activation and synchronization. J Nucl Cardiol 2006;13:811-20.CrossRefPubMedGoogle Scholar
  27. 27.
    Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Interventricular and intraventricular cardiomyopathy dyssynchrony in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:2022-30.CrossRefPubMedGoogle Scholar
  28. 28.
    O’Conell JW, Schreck C, Moles M, Badwar N, DeMarco T, Olgin J, et al. A unique method by which to quantitate synchrony with equilibrium radionuclide angiography. J Nucl Cardiol 2005;12:441-50.CrossRefGoogle Scholar
  29. 29.
    Peix A, Ponce F, Zayas R, Lopez A, Cabrera O, Dorticós F, et al. Evaluation of ventricular synchronization by Fourier Phase analysis in radionuclide ventriculography. Rev Esp Med Nuclear 2003;22:26-9.CrossRefGoogle Scholar
  30. 30.
    Henneman M, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenbrg C, et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med. 2007;48:1104-111.CrossRefPubMedGoogle Scholar
  31. 31.
    Henneman M, Chen J, Ypenbourg C, Dibbets P, Bleeker G, Boersma E, et al. Phase analysis of gated myocardial perfusion single photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007;49:1708-14.CrossRefPubMedGoogle Scholar
  32. 32.
    Ortega-Alcalde D. Parametric images and Fourier analysis. In: Candell-Riera J, Ortega-Alcalde D, editors. Nuclear cardiology in everyday practice. Dordrecht: Kluver Academic; 1994. p. 173-86.CrossRefGoogle Scholar
  33. 33.
    Westenberg JJ, Lamb HJ, van der Geest RJ, Bleeker G, Holman E, Schalij M, et al. Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy: head-to-head comparison between tissue Doppler imaging and velocity-encoded magnetic resonance imaging. J Am Coll Cardiol. 2006;47:2042-48.CrossRefPubMedGoogle Scholar
  34. 34.
    Somsen GA, Verberne HJ, Burri H, Ratib O, Rignetti A. Ventricular mechanical dyssynchrony and resynchronization therapy in herat failure: a new indication for Fourier analysis of gated blood-pool radionuclide ventriculography. Nucl Med Commun. 2006;27:105-12.CrossRefPubMedGoogle Scholar
  35. 35.
    Donal E, Leclercq Ch, Linde C, Daubert JC. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J. 2006;27:1018-25.CrossRefPubMedGoogle Scholar
  36. 36.
    Herre J. Keys to successful cardiac resynchronization therapy. Am Heart J 2007;153(4 Suppl):18-24.CrossRefPubMedGoogle Scholar
  37. 37.
    Santomoro M, Pace L, Duillo C, Ottavaino L, Borrelli A, Ferro A, et al. Left ventricular pacing in patients with heart failure evaluation study with Fourier analysis of radionuclide ventriculography. Ital Heart J. 2004;5:906-11.Google Scholar
  38. 38.
    Le Rest C, Coutier O, Turzo A, Guillo P, Bizais Y, Etienne Y, et al. Use of left ventricular pacing in heart failure: evaluation by gated blood pool imaging. J Nucl Cardiol. 1999;6:651-6.CrossRefPubMedGoogle Scholar
  39. 39.
    Auricchio A, Yu CM. Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronization therapy in heart failure. Heart. 2004;90:479-81.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Schuster P, Faerestrand S, Ohm OJ. Reverse remodelling of systolic left ventricular contraction pattern by long term cardiac resynchronization therapy: colour Doppler shows resynchronization. Heart. 2004;90:1411-6.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Botvinick EH. Scintigraphic blood pool phase image analysis: the optimal tool for the evaluation of resynchronization therapy. J Nucl Cardiol 2003;10:424-8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Africa Muxí
    • 1
    • 3
    Email author
  • Pilar Paredes
    • 1
  • Lluis Mont
    • 2
    • 3
  • Francisco J. Setoain
    • 1
    • 3
  • Joan Duch
    • 1
  • Silvia Fuertes
    • 1
  • Jaime Ortín
    • 1
  • Ernesto Diaz-Infante
    • 2
  • Francisca Pons
    • 1
    • 3
  1. 1.Nuclear Medicine Department (Centre de Diagnóstic per la Imatge, CDI)Hospital Clínic, Universitat de BarcelonaBarcelonaSpain
  2. 2.Cardiology Department (Institut Clínic del Tórax, ICT)Hospital Clínic, Universitat de BarcelonaBarcelonaSpain
  3. 3.Institut d`Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS)BarcelonaSpain

Personalised recommendations